MustangBio
    • About
      • About Mustang Bio
      • Leadership
      • Board of Directors
      • In the News
      • Contact
    • Our Approach
      • Our Approach
      • About CAR T Cell Therapy
      • Publications
    • Pipeline
      • Pipeline
      • Clinical Trials
    • Partnering
      • Partnering
      • Active Collaborations
    • Careers
    • Investor Relations
      • News & Events
      • Company Info
      • Financial Info
      • Stock Data
      • SEC Filings
      • Governance
    MustangBio
      • About
        • About Mustang Bio
        • Leadership
        • Board of Directors
        • In the News
        • Contact
      • Our Approach
        • Our Approach
        • About CAR T Cell Therapy
        • Publications
      • Pipeline
        • Pipeline
        • Clinical Trials
      • Partnering
        • Partnering
        • Active Collaborations
      • Careers
      • Investor Relations
        • News & Events
        • Company Info
        • Financial Info
        • Stock Data
        • SEC Filings
        • Governance

      Press Releases

      Investors

      Investors

      • Overview
      • News & Events
        • Overview
        • Press Releases
        • IR Calendar
        • Email Alerts
      • Company Info
        • Overview
        • Management Team
        • Presentations
        • Contacts
        • FAQ
      • Financial Info
        • Overview
        • Financial Results
        • Income Statement
        • Balance Sheet
        • Cash Flow
      • Stock Data
        • Quote
        • Charts
        • Historical Data
      • SEC Filings
        • Overview
        • All SEC Filings
        • Annual Reports
        • Quarterly Reports
        • Section 16 Filings
      • Governance
        • Overview
        • Board of Directors
        • Board Committees
        • Governance Documents
      • News & Events

      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
          November 1, 2017

          Mustang Bio Announces MB-102 Data Selected for Oral Presentation at 59th American Society of Hematology Annual Meeting

          October 31, 2017

          Mustang Bio Reports Preclinical Data on Regional Delivery of MB-103 HER2 Chimeric Antigen Receptor Engineered T (CAR T) Cells to Target HER2+ Breast Cancer Metastasis to the Brain

          October 30, 2017

          Mustang Bio Establishes CAR T Cell Therapy Manufacturing Facility in Massachusetts

          October 11, 2017

          Mustang Bio Announces $12.8 Million Grant to Fund Phase 1 Trial of CAR T Therapy MB-101 in Malignant Glioma

          September 14, 2017

          Mustang Bio Announces Expansion of CAR T Pipeline into CD20-Directed Immunotherapies

          September 5, 2017

          Mustang Bio to Present at the CAR-TCR Summit 2017

          August 22, 2017

          Mustang Bio Commences Trading on the NASDAQ Global Market

          • arrow_back
          • 1
          • …
          • 10
          • 11
          • 12
          • 13
          • 14
          • 15
          • 16
          • 17
          • 18
          • 19
          rss_feed News RSS
          • Email Alerts
          • Contacts
          • RSS News Feed

          95 Sawyer Road, Suite 110 • Waltham, MA 02453

          781-652-4500 info@mustangbio.com

          Twitter Linkedin

          © Copyright 2025 Mustang Bio